PanTheryx said June 26 that it raised $50 million in financing from Perceptive Advisors. PanTheryx, of Boulder, Colorado, is a biotech that is focused on addressing serious GI related health conditions. Armentum Partners acted as financial adviser to PanTheryx. PRESS RELEASE PanTheryx Announces $50 Million Financing, Accelerates Development of its Novel Biologics and Medical Foods Candidates BOULDER,

BILLERICA, Mass., June 25, 2019 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient’s unique anatomy, announced today that the Company has secured up to $30 million in debt financing from Innovatus Capital Partners, LLC (“Innovatus”) and East West Bank and $3

ALEXANDRIA, Va. and HAYWARD, Calif., May 1, 2019 — Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, has completed the closing of a $60 million senior secured term loan with RefleXion Medical, Inc., a biotargeting oncology company developing the first and only biology-guided

-Financing Strengthens Cash Position Ahead of Two Potential Product Launches in 2019- December 21, 2018 07:00 ET | Source:  Nabriva Therapeutics US, Inc DUBLIN, Ireland, Dec. 21, 2018 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections, today announced the closing

BRIDGEWATER, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) — Nevakar Inc., a specialty pharmaceutical company developing multiple differentiated products in the ophthalmic and injectable areas, announced today that it has entered into a $20 million senior secured term loan with Oxford Finance LLC. As part of the financing agreement, Nevakar may also access an additional $10